- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Undervalued based on future growth
Canadian Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
2 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Green Thumb Industries
Market Cap: CA$1.6b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
New
GTII
CA$6.71
7D
-6.4%
1Y
-56.6%
Medexus Pharmaceuticals
Market Cap: CA$94.5m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.93
7D
3.2%
1Y
89.0%
Decibel Cannabis
Market Cap: CA$40.4m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
New
DB
CA$0.07
7D
0%
1Y
0%